Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kathleen Laporte currently holds 23,272 shares of Bolt Biotherapeutics, Inc. (BOLT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathleen Laporte has been a net seller of BOLT stock. They have purchased $24.0K and sold $18.9M worth of shares.
Kathleen Laporte's most recent insider trade was on Jan 15, 2026, when they sold 23,272 shares at $2.75 per share.
Kathleen Laporte serves as Executive at Bolt Biotherapeutics, Inc. (BOLT). They have executed 65 insider transactions totaling $18.9M over their tenure at the company.
Kathleen Laporte holds the position of Executive at Bolt Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 22 years and currently hold a stake valued at $0.
Kathleen Laporte has shown a selling trading pattern, with $24.0K in total purchases and $18.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kathleen Laporte was on Apr 13, 2011, when they sold $13.0M worth of ISTA shares. This transaction involved 1,235,419 shares at $10.49 per share.
Kathleen Laporte currently owns 23,272 shares of Bolt Biotherapeutics, Inc. (BOLT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kathleen Laporte's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kathleen Laporte has 65 Form 4 filings on record as an insider at Bolt Biotherapeutics, Inc..
Set alerts for Kathleen Laporte and 40,000+ other insiders.